GESI SALUD IPS: public contracts won without a rival in Colombia: 2 uncontested awards; 7% of its awards; 2 without a competition; 0 single bid.
Assay record ASY-CO-0S9R7RC0NP · Cite as: Assay Systems, “GESI SALUD IPS: public contracts won without a rival in Colombia”, https://assay-systems.com/register/co/uncontested/s/gesi-salud-ips/
GESI SALUD IPS won 2 of its 27 public contract awards in Colombia without a rival from 2022-10-31 to 2025-07-14: 2 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest EMPRESA SOCIAL DEL ESTADO HOSPITAL EMIRO QUINTERO CAÑIZARES 12 with 1.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
EMPRESA SOCIAL DEL ESTADO HOSPITAL EMIRO QUINTERO CAÑIZARES 12 gave GESI SALUD IPS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2025-07-14, latest 2025-07-14.
ESE HOSPITAL MENTAL RUDESINDO SOTO gave GESI SALUD IPS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2022-10-31, latest 2022-10-31.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2025-07-14 | EMPRESA SOCIAL DEL ESTADO HOSPITAL EMIRO QUINTERO CAÑIZARES 12 CO1.PCCNTR.8069875 | No competition Contratación régimen especial | Regla aplicable |
| 2022-10-31 | ESE HOSPITAL MENTAL RUDESINDO SOTO CO1.PCCNTR.4149773 | No competition Contratación régimen especial | Regla aplicable |
Every uncontested award in Colombia · All countries
Source: SECOP II, Colombia Compra Eficiente open data (datos.gov.co). Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.